Led by Rachel Blount - Global Technical Consultant Manager and Pharmig Committee Member

Disinfectant efficacy validation testing can be a daunting task as there are various factors to consider. There are a number of standardized test methods available that can be used to demonstrate disinfectant efficacy. However, there are differences between the methods generally used in the EU and the US and all existing standards have individual pitfalls and unique challenges, all of which can lead to variation in results.

Currently, there are few detailed and explicit regulatory expectations with regards to disinfectant efficacy testing that end-users should perform, but there are guidance documents available which should be considered when embarking on this task.

It is important to note that the existing methods are not specifically designed for cleanroom disinfectants and so modifications to the methods to reflect a cleanroom environment should be considered, with the support of guidance documents such as (USP) 40-NF35 Chapter 1072.

The purpose of this presentation is to provide guidance to end users of disinfectant products to help them produce a strategy and rationale for their disinfectant validation testing that is in line with a global harmonized approach. The use of a harmonized method can give companies a transferable platform to achieve replicable results between laboratories and between countries.

FEES: Pharmig Member £70 sterling / Non Member £100 sterling